Olalekan Olasehinde
Overview
Explore the profile of Olalekan Olasehinde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Romanoff A, Olasehinde O, Lynch K, Folorunso S, Omoyiola O, Omolade B, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2459614.
PMID: 39937473
Importance: In Nigeria, 80% of breast cancer is diagnosed at an advanced stage, when clinical management is complex and necessitates multidisciplinary collaboration. The Nigerian Federal Ministry of Health promotes multidisciplinary...
2.
Mustapha B, Alatise O, Olasehinde O, Adisa A, Wuraola F, Mohammed T, et al.
World J Surg
. 2024 Nov;
49(2):334-342.
PMID: 39578689
Background: Hemorrhoidectomy is considered as the most effective approach for patients with grade III and grade IV hemorrhoids; the operative procedure may be associated with significant postoperative pain and other...
3.
Aderibigbe A, Dare A, Kalvin H, Olasehinde O, Wuraola F, Adisa A, et al.
J Surg Oncol
. 2024 Nov;
PMID: 39574208
Background And Objectives: Prospective data on presentation and outcomes of colorectal cancer (CRC) in Nigeria are limited; however, emergency presentation with advanced disease is thought common. Methods: Consecutive CRC patients...
4.
Yibrehu B, Mohammed T, Murthy S, Aderibigbe A, Daramola O, Arije O, et al.
J Surg Oncol
. 2024 Nov;
PMID: 39558548
Background: In Nigeria, gastric cancer is the 10th most common and 9th most deadly malignancy. The limited availability of robust data makes further characterizing it challenging. The objective of this...
5.
Wuraola F, Blackman C, Olasehinde O, Aderounmu A, Adeleye A, Omoyiola O, et al.
J Cancer Policy
. 2024 Nov;
42():100518.
PMID: 39522636
Background: Most patients pay out-of-pocket for cancer care in Nigeria, which can result in a catastrophic health care expenditure (CHE). There is a paucity of economic data on the cost...
6.
Onwuka J, Wuraola F, Owoade I, Ogunyemi Y, Di Bernardo M, Dare A, et al.
JCO Glob Oncol
. 2024 Oct;
10():e2400060.
PMID: 39418630
Purpose: The incidence of GI cancers is increasing in sub-Saharan African countries. We described the oncological care pathway and assessed presentation, diagnosis, and treatment intervals and delays among patients with...
7.
Olasehinde O, Fagbayimu M, Aderounmu A, Komolafe T, Ameen M, Alatise O, et al.
Breast Care (Basel)
. 2024 Jun;
19(3):135-141.
PMID: 38894956
Introduction: In Nigeria, mastectomy is the most common surgical treatment for breast cancer. Patients are often kept on admission for days until wound drains are removed. An early discharge programme...
8.
Alatise O, Yibrehu B, Jackman J, Arije O, Olasehinde O, Keli E, et al.
HPB (Oxford)
. 2024 Jun;
26(9):1123-1130.
PMID: 38862377
Background: West Africa has among the highest rates of hepato-pancreato-biliary (HPB) malignancies in the world. Although surgery is critical for treatment, the availability of HPB surgery in Africa is unknown....
9.
Jackman J, Yibrehu B, Doyle A, Alatise O, Wuraola F, Olasehinde O, et al.
J Surg Oncol
. 2024 Apr;
129(7):1374-1383.
PMID: 38624014
Globally, cancer is the second leading cause of death, and low- and middle-income countries bear most of the disease burden. While cancer is increasingly recognized as a major global health...
10.
Aderounmu A, Olasehinde O, Wuraola F, Adisa A, Lawal O
J West Afr Coll Surg
. 2024 Apr;
14(2):154-158.
PMID: 38562382
Background: Interest in surgical site infections (SSI) has been sustained over the years because its occurrence may be ruinous to the overall success of surgical operations. The use of antimicrobial...